Zhang, Y., Ran, L., Liang, Y., Zhang, Y., & An, Z. (2023). Safety analysis of pemigatinib leveraging the US Food and Drug administration adverse event reporting system. Frontiers Media S.A.
Chicago Style (17th ed.) CitationZhang, Ying, Li Ran, Yongchao Liang, Yanqiu Zhang, and Zhuoling An. Safety Analysis of Pemigatinib Leveraging the US Food and Drug Administration Adverse Event Reporting System. Frontiers Media S.A, 2023.
MLA (9th ed.) CitationZhang, Ying, et al. Safety Analysis of Pemigatinib Leveraging the US Food and Drug Administration Adverse Event Reporting System. Frontiers Media S.A, 2023.
Warning: These citations may not always be 100% accurate.